搜索到 1000 条关于 14a일수디비홍보디비%I텔DaisoDBI☑️ 的文章
-
2024.08.12 14 人入选,国家最高荣誉公示
来源:新华社据新华社消息,8 月 12 日,党和国家功勋荣誉表彰工作委员会办公室发布《关于 「 共和国勋章 」 和国家荣誉称号建议人选的公示》。今年是中华人民...
-
-
2019.10.25 14. 伯乐伴我科研路
从读大学开始,就认识了伯乐。刚进实验室,屁颠屁颠跟在师兄师姐后面,看着他们做 WB,做 PCR,偶尔自己操作一下仪器,感觉伯乐的仪器还是比较容易上手的。后来读研...
-
-
2015.05.27 06-14 神经护理论坛
-
-
2015.05.27 06-14 国际会场(英文)
-
-
2015.05.27 06-14 卒中热点论坛
-
2012.09.19 【免注册费】上海分子流行病学与GWAS会议国际研讨会
分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析(GWAS)为全面系统研究复杂疾病的遗传因素掀开了新的一页,为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因,我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目,吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员,特别是广大研究生了解GWAS的研究原理和方法,学会设计GWAS的研究和分析实验结果,同时在癌症领域分享海内外研究专家们的成功经验,并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加,请有意者及时将回执返回联系邮箱。免注册费(食宿餐饮费用自理)。名额有限,报名从速!时间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆 上海市邯郸路220号,200433
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹 高歌 联系电话: 021-55664495
回执邮箱: GWAS2009@gmail.com
BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时 间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹,高歌 (Shanghai, China);Tamara Adams (U.S.)
联系电话: 21-55664495 (Shanghai, China);336-713-7532 (U.S.)
回执邮箱: GWAS2009@gmail.com (Shanghai, China);tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
• Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factors• S. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer
-
-
2016.10.11 ECT 治疗抑郁症后 怎么维持才最好?
研究呢,则是当 I 期研究成功结束后,与单独用药相比,使用持续 ECT+药物治疗治疗老年抑郁患者的有效性和耐受性。来自美国纽约西奈山医学院精神科的...了 I 期研究。纳入的患者其年龄均在 60 岁以上,中位年龄为 69.9 岁,抑郁症再发的占了 87.5%,精神病性和忧郁型分别占了 11.7% 和 59
-
-
2016.01.04 儿童成人都不差:拉莫三嗪可应用于儿童双相障碍
剂,不仅可用于双相障碍的急性期,在维持治疗中也发挥了不可或缺的作用。2003 年美国食品与药物管理局(FDA)正式批准其可用于成人双相 I 型维持治疗。那么拉莫三嗪...) 双相障碍 I 型辅助维持治疗中的疗效、安全性及耐受性等。研究结果发表于 2015 年 12 月 J Am Acad Child Adolesc
-
-
2009.08.19 欧盟修改非选择性α阻断剂产品信息
(PDE-5-I)导致血压降低的评估结论。口服PDE-5-I和非选择性α阻断剂可分别用于治疗勃起机能障碍和良性前列腺增生。大约有50%的男性在50岁左右...药品不良反应数据库所收到的自发报告、3种PDE-5-I的参考信息。在对药品安全性的讨论期间,非选择性α阻断剂的相关上市许可持有者可能已经主动在药品
-
-
2016.05.26 ASCO2016:「三明治」方案可治疗 NK/T 细胞淋巴瘤
华西医院肿瘤科的张洪等进行了关于LVDP 联合同步化疗(CCRT)「三明治」法治疗 I/II 期鼻型结外 NK/T 细胞淋巴瘤...会(ASCO)年会上进行壁报展出。该研究共纳入了 70 例新近诊断的 I/II 期 ENKTCLs 患者,并提出了新的「三明治」方案——左旋门冬酰胺酶、顺铂
-
-
2014.03.11 临床妊娠期妇女禁用药物
:阿维A酸+阿维A阿维A是阿维A酸的活性代谢物。阿维A与乙醇混合使用可使阿维A转变为阿维A酸。阿维A酸致畸作用的报道包括:脊髓脊膜膨出、脑脊脑膨出、多骨...“胎儿酒精中毒综合征”,妊娠期安全饮酒量的标准还不清楚,有可能产生胎儿脑毒性!十:异维甲酸(异维A酸)任何剂量在短时间内应用都可以发生
-
2006.02.20 环孢素A治疗肾小球疾病的应用--2005年专家共识
环孢素A(cyclosporin A,CsA)为11个氨基酸组成的环形多肽,是从土壤霉菌种分离出来的一种强效、选择性高的免疫抑制剂。CsA广泛用于器官移植...为减少肾血流量,降低肾小球滤过压。 一、环孢素A应用于治疗原发病肾病综合征 CsA是治疗原发性肾病综合征的二线药物,主要用于难治性肾病综合征或对
-
2012.09.19 临床心理护理理论与技术的新进展+护理英语口语培训班
“临床心理护理理论与技术的新进展”培训班项目编号:2010-14-05-215项目学分:国家I类10分...实例解析”。“护理专业英语在教学及临床实践中的应用”培训班项目编号:2010-14
-
-
2014.10.24 后纵隔神经纤维瘤罕见并发症一例
证实。图2:(a)术中图片。肿瘤(箭头);(B)中切下的肿瘤;(三)皮肤神经纤维瘤的病变。I:无名动脉;T:气管。...近日来自希腊雅典奥纳西斯心脏外科中心的Andrew Chatzisa教授等人在EJCS杂志上发表了一例罕见的后纵隔神经纤维瘤患者,现编译如下:患者,男,14岁
-
-
2016.01.18 早期肺癌:立体定向放射治疗不如手术
以往研究纳入的病例数量有限,来自美国华盛顿大学的 Puri 医生利用美国国家癌症数据库(NCDB)回顾了手术治疗与 SBRT 在 I 期肺癌患者中的相关数据... 数据库中 111731 例行手术治疗患者,与 5887 例行 SBRT 的 I 期肺癌患者数据,分析比较了两组患者年龄,性别,肿瘤大小,临床 T 分期与总体中位
-
-
2015.04.23 华西 14 名医生联名上书 要求还医者尊严
今日一封联名抗议书引爆医疗圈。四川大学华西第二医院 14 名医护人员因不堪患者及其家属对该院杨医生的无理取闹和恐吓威胁,联名抗议,拒绝为该病人提供任何服务...,是希望,我无条件声援签名的 14 名医生,挺住!「懂得维护自己基本的安全和尊严,这是医者最起码的要求。这样的声明,有血性、有原则、有担当。」「对于患者,无论高低贵贱
-
2012.09.19 2012北京男科论坛--暨男科疾病临床应对策略研讨会
I类继续医学教育学分(7分)论坛主旨规范诊疗:规范男科常见疾病临床诊治途径面向基层:面向国内、面向基层,为男科专科年轻医生及基层...10.精液分析的标准化研究11.雄激素与雄激素缺乏12.男性不育的治疗策略13.男性不育的显微外科治疗14.男科手术的现状与进展
-
2012.09.19 2010重庆·首届足踝疾病诊治高级讲座及手术操作培训班
足踝疾病在临床十分常见,但较多骨科医生缺乏对其规范化诊治的培训。为此,我们特举办高级讲座和操作培训班,学习内容强调实用性和可操作性,注册的培训学员将在国内外专家指导下进行新鲜尸体操作。学员可获得国家继续教育I类学分。会议主办:中华医学会重庆市骨科专委会及中西医结合学会重庆市骨科专委会。会议承办:第三军医大学附属
-
International Conference on Biomedical Engineering
) will be held on Jun. 14-16 2013 in Beijing, China. This Conference will cover issues on Biomedical Engineering. It dedicates to creating a stage for exchanging the latest
-
International Conference on Signal and Image Processing
) will be held on July 14 to 16, 2013 in Beijing, China. This Conference will cover issues on Signal and Image Processing. It dedicates to creating a stage for exchanging
